Dr. Mitchell Wolin, MD

NPI: 1457342867
Total Payments
$1,372
2023 Payments
$247.07
Companies
13
Transactions
44
Medicare Patients
978
Medicare Billing
$69,203

Payment Breakdown by Category

Food & Beverage$1,330 (96.9%)
Education$42.39 (3.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,330 41 96.9%
Education $42.39 3 3.1%

Top Paying Companies

Company Total Records Latest Year
Aerie Pharmaceuticals, Inc. $233.96 3 $0 (2019)
Horizon Therapeutics plc $188.98 4 $0 (2023)
Omeros Corporation $186.09 5 $0 (2019)
ANI Pharmaceuticals, Inc. $182.19 7 $0 (2023)
TOPCON MEDICAL SYSTEMS, INC. $131.44 1 $0 (2017)
Bausch & Lomb, a division of Bausch Health US, LLC $126.19 8 $0 (2020)
Allergan, Inc. $70.24 4 $0 (2020)
AbbVie, Inc. $63.25 3 $0 (2018)
Carl Zeiss Meditec, Inc. $55.89 1 $0 (2018)
Mallinckrodt LLC $42.39 3 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $247.07 8 ANI Pharmaceuticals, Inc. ($182.19)
2022 $49.73 1 Horizon Therapeutics plc ($49.73)
2020 $160.46 7 Horizon Therapeutics plc ($74.37)
2019 $396.45 12 Omeros Corporation ($186.09)
2018 $272.21 8 Aerie Pharmaceuticals, Inc. ($131.13)
2017 $246.53 8 TOPCON MEDICAL SYSTEMS, INC. ($131.44)

All Payment Transactions

44 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/09/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $20.41 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
08/31/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $70.02 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
06/30/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $29.53 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
04/28/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $27.10 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
03/27/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $6.77 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
03/13/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $64.88 General
Category: TEPEZZA
01/05/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $15.56 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
01/05/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $12.80 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
02/14/2022 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $49.73 General
Category: TEPEZZA
12/03/2020 Allergan, Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $12.48 General
Category: OPHTHALMOLOGY
11/03/2020 Allergan, Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $21.36 General
Category: OPHTHALMOLOGY
08/31/2020 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $14.28 General
Category: TEPEZZA
08/25/2020 Allergan, Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $15.80 General
Category: OPHTHALMOLOGY
07/09/2020 Allergan, Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $20.60 General
Category: OPHTHALMOLOGY
03/12/2020 Bausch & Lomb, a division of Bausch Health US, LLC PROLENSA (Drug), LOTEMAX SM Food and Beverage In-kind items and services $15.85 General
Category: OPHTHALMOLOGY
03/11/2020 Horizon Therapeutics plc Food and Beverage In-kind items and services $60.09 General
12/05/2019 Omeros Corporation Omidria (Drug) Food and Beverage Cash or cash equivalent $6.40 General
Category: Ophthalmology
10/30/2019 Omeros Corporation Omidria (Drug) Food and Beverage Cash or cash equivalent $19.68 General
Category: Ophthalmology
10/29/2019 Omeros Corporation Omidria (Drug) Food and Beverage Cash or cash equivalent $16.63 General
Category: Ophthalmology
08/20/2019 Bausch & Lomb, a division of Bausch Health US, LLC PROLENSA (Drug), LOTEMAX SM Food and Beverage In-kind items and services $17.48 General
Category: OPHTHALMOLOGY
08/20/2019 Bausch & Lomb, a division of Bausch Health US, LLC PROLENSA (Drug), LOTEMAX SM Food and Beverage In-kind items and services $14.22 General
Category: OPHTHALMOLOGY
06/17/2019 Bausch & Lomb, a division of Bausch Health US, LLC CRYSTALENS (Device) Food and Beverage In-kind items and services $22.41 General
Category: OPHTHALMOLOGY
06/06/2019 Aerie Pharmaceuticals, Inc. Rhopressa (Drug), Rocklatan Food and Beverage In-kind items and services $102.83 General
Category: Glaucoma
05/20/2019 Bausch & Lomb, a division of Bausch Health US, LLC PROLENSA (Drug), LOTEMAX Food and Beverage In-kind items and services $11.17 General
Category: OPHTHALMOLOGY
03/06/2019 Omeros Corporation Omidria (Drug) Food and Beverage Cash or cash equivalent $25.75 General
Category: Ophthalmology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 7 176 180 $36,114 $9,535
2020 11 802 896 $166,882 $59,668
Total Patients
978
Total Services
1,076
Medicare Billing
$69,203
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 32 33 $9,273 $3,192 34.4%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 32 32 $7,744 $1,608 20.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 17 17 $5,355 $1,454 27.2%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 29 30 $5,070 $1,342 26.5%
92060 Measurement of eye muscles to detect deviation of eyeball Office 2021 22 23 $2,990 $857.01 28.7%
92083 Measurement of field of vision during daylight conditions, extended examination Office 2021 17 17 $2,686 $541.63 20.2%
92133 Diagnostic imaging of optic nerve of eye Office 2021 27 28 $2,996 $540.10 18.0%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 118 118 $34,146 $13,650 40.0%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 167 182 $36,544 $13,583 37.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 112 128 $35,937 $13,243 36.9%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2020 98 117 $15,741 $5,626 35.7%
92060 Measurement of eye muscles to detect deviation of eyeball Office 2020 107 130 $16,025 $5,207 32.5%
92083 Measurement of field of vision during daylight conditions Office 2020 64 73 $9,585 $2,500 26.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 31 34 $5,491 $1,914 34.9%
92133 Diagnostic imaging of optic nerve of eye Office 2020 64 68 $6,815 $1,781 26.1%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2020 19 19 $4,577 $1,520 33.2%
92134 Diagnostic imaging of retina Office 2020 11 11 $1,221 $340.53 27.9%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 11 16 $800.00 $303.39 37.9%

About Dr. Mitchell Wolin, MD

Dr. Mitchell Wolin, MD is a Ophthalmology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457342867.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Wolin, MD has received a total of $1,372 in payments from pharmaceutical and medical device companies, with $247.07 received in 2023. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,330).

As a Medicare-enrolled provider, Wolin has provided services to 978 Medicare beneficiaries, totaling 1,076 services with total Medicare billing of $69,203. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Greenville, SC
  • Active Since 11/03/2005
  • Last Updated 02/18/2020
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1457342867

Products in Payments

  • Rhopressa (Drug) $233.96
  • PURIFIED CORTROPHIN GEL (Drug) $182.19
  • OCT-MAESTRO (Device) $131.44
  • TEPEZZA (Drug) $128.89
  • OMIDRIA (Drug) $117.63
  • PROLENSA (Drug) $79.03
  • LUMIGAN (Drug) $70.24
  • Omidria (Drug) $68.46
  • OPMI Lumera (Device) $55.89
  • Humira (Biological) $48.12
  • ACTHAR (Biological) $42.39
  • CRYSTALENS (Device) $22.41
  • Tecnis Multifocal Family of 1-piece IOLS (Device) $22.04
  • XELPROS (Drug) $20.21
  • LOTEMAX GEL (Drug) $18.88
  • SOFPORT AO (Device) $16.32
  • Tecnis 1-piece IOL (Device) $14.38
  • BESIVANCE (Drug) $12.60
  • VYZULTA (Drug) $12.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Greenville